Source: Annual Congress 2008 - Improved diagnosis and clinical decision-making by integrating information from new biomarkers



Rating:

Share or cite this content

Citations should be made in the following way:
M. Christ-Crain (Basel, Switzerland). Pro-adrenomedullin as prognostic marker in patients with CAP. Annual Congress 2008 - Improved diagnosis and clinical decision-making by integrating information from new biomarkers

Member's Comments

No comment yet.

Related content which might interest you: Is YKL-40 a prognostic marker in sarcoidosis? Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 The prognostic value of procalcitonin in patients with hypoxemic COVID 19 pneumonia. Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 The clinical and prognostic evaluation of patients with PAH Source: Annual Congress 2012 - Exercise testing in pulmonary arterial hypertension patients Year: 2012 Proadrenomedullin (proADM) for clinical severity and prognosis in patients with pneumonia Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 Mortality risk prediction in COPD by a prognostic biomarker panel Source: Eur Respir J 2014; 44: 1557-1570 Year: 2014 Determining the prognostic value of procalcitonin in ICU patients who developed hospital acquired pneumonia and comparing with sencitive CRP Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Prognostic nutritional index (PNI): A predictive factor for elderly patients with COPD Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Diagnostic and prognostic value of C-reactive protein in community-acquired pneumonia hospitalized patients Source: Eur Respir J 2004; 24: Suppl. 48, 188s Year: 2004 Prognostic values of biomarkers in COPD Source: Annual Congress 2013 –Natural history of COPD: novel aspects Year: 2013 Prognostic value of neutrophil-to-lymphocyte ratio in hospitalized patients with COVID-19 Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Diagnostic and prognostic utility of procalcitonin (PCT) measurements in patients with hospitalized community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Prognostic value of detecting the HLA genetic markers in patients from risk groups for TB Source: Eur Respir J 2003; 22: Suppl. 45, 341s Year: 2003 The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients. Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Circulating total leptin as a diagnostic and prognostic biomarker in sepsis Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 eNAMPT as a novel diagnostic and prognostic biomarker in critically ill septic patients Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018 Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 The prognostic value of some clinical and laboratory parameters in sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002 Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker? Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Prognostic predictors for survival in patients with COPD using cardiopulmonary testing Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002